NR4A1 and breast carcinoma: Finally, epidemiological evidence shows that there is a reduced risk of hormone receptor-positive, but not hormone receptor-negative, breast cancer incidence in women who regularly take non-steroidal anti-inflammatory drugs (NSAIDs) [90].